TITLE:
Growth Hormone Releasing Hormone Receptors Antagonists and Cancers: Do GHRH-R Antagonists Play a Role in the Management of Prostate Cancer?
AUTHORS:
Joseph Bertin Alexis Zoa Bindzi, Yingjie Yang, Xiaoqi Yan, Yi Zhong, Yuantong Tian
KEYWORDS:
GHRH, Receptors, Antagonists, Prostate, Cancer
JOURNAL NAME:
Open Journal of Urology,
Vol.10 No.6,
May
28,
2020
ABSTRACT: Growth hormone-releasing hormone (GHRH) and its receptors have been implicated in the progression of various tumors such as those of the prostate. Treatment modalities for prostate cancer in a localized stage or when it is still castration-sensitive yield good results in most patients. However, such treatments are only palliative in the advanced stage. Therefore, new therapeutic targets like growth hormone-releasing hormone receptor (GHRH-R) and its splice variants should be found in order to get effective treatments for more aggressive stages in prostate cancer. This review talks about the GHRH-R and its splice variants, the signaling pathways induced by GHRH to produce cancer, the structure activity relationship of GHRH-R antagonists and the resume of some in vitro and in vivo studies on the role of GHRH-R antagonists in the treatment of prostate cancer.